2471 - 2480 of 8808 Results
Title
Year
-
OPENTitle: Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2174End Page: 2183Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28220Best OA location URL: https://doi.org/10.1002/mds.28220Citation Count: 32
-
OPENTitle: Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 PandemicJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1295End Page: 1296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28205Citation Count: 24
- Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration2020OPENTitle: Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated NeurodegenerationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1342End Page: 1352Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28392Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28392Citation Count: 24
- Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease2020OPENTitle: Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1233End Page: 1238Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28026Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28026Citation Count: 30
-
OPENTitle: A Gain‐of‐Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant TherapyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1868End Page: 1873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28138Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7572833Citation Count: 33
-
OPENTitle: Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2249End Page: 2257Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29610Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2024-00014%22Citation Count: 17
-
RESTRICTEDTitle: Adherence and Efficacy of Olfactory Training as a Treatment for Persistent Olfactory LossJournal Name: American Journal of Rhinology & AllergyPublisher: SAGE PublicationsVol: 34Issue #: 2Start Page: 238End Page: 248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1945892419887895Citation Count: 24
- Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs2018OPENTitle: Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI InputsJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 290Issue #: 3Start Page: 649End Page: 656Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/radiol.2018180940Citation Count: 221
-
OPENTitle: A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancerJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 40Issue #: 4Start Page: 799End Page: 807Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0271678x19843776Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X19843776Citation Count: 45
-
OPENTitle: Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 879End Page: 899Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-019-01962-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6533145Citation Count: 106